A Study of Fostamatinib in Subjects With Impaired Kidney Function
| Status: | Archived |
|---|---|
| Conditions: | Arthritis, Renal Impairment / Chronic Kidney Disease, Rheumatoid Arthritis |
| Therapuetic Areas: | Nephrology / Urology, Rheumatology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | November 2010 |
| End Date: | January 2011 |
An Open-label, Phase I Study to Assess the Pharmacokinetics of R406 in Subjects With Renal Impairment Compared to Healthy Subjects Following Administration of a Single Dose of Fostamatinib 150 mg
A 2 stage study to evaluate the amount of fostamatinib in the blood and urine in subjects
with impaired kidney (renal) function compared with healthy volunteers with normal renal
function. Stage 1 will include healthy subjects and subjects with end stage renal disease,
while Stage, 2 may include subjects with mild, moderate and/or severe renal impairment
dependent on the outcome of Stage 1. The study will also evaluate safety and tolerability
in subjects with renal impairment.
We found this trial at
1
site
Click here to add this to my saved trials
